Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Search
Medicines Law & Policy
Research and resources on intellectual property and health
Home
Covid-19
Tools
Introduction to the Tools
Model Government Use Licences
Model Uses of Paragraph 7 or “LDC Waiver”
Special Compulsory Licences for Export of Medicines
Options for Regional Economic Communities
Voluntary Licences
TRIPS Flexibilities Database
Resources
Briefs & Briefing Documents
Publications
Tools
Useful Links
All Resources
Blog
About
Tag: Cancer
Wrapping up 2022 with some noteworthy medicines, law and policy events
Medicines Law & Policy
-
December 22, 2022
WHO’s Essential Medicines Committee takes aim at rising prices, adds new...
Kaitlin Mara
-
October 6, 2021
Wrapping up 2019 – Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 30, 2019
Socially Responsible Licensing of Medical Technologies
Ellen 't Hoen
-
December 9, 2019
Strong call for transparency on medicine prices, cost of R&D at...
Ellen 't Hoen
-
April 19, 2019
Cancer Drug Pricing on the World Health Organization’s Executive Board Agenda
Ellen 't Hoen
-
January 23, 2019
Time to put a stop to the abuse of orphan drug...
Ellen 't Hoen
-
January 9, 2019
2018 Round-up of Noteworthy Medicines Law and Policy Events
Ellen 't Hoen
-
December 26, 2018
WIPO and pharma industry launch global medicines patent database
Ellen 't Hoen
-
September 27, 2018
European Pharmaceutical Legislation Needs Exceptions to Data and Market Exclusivity to...
Ellen 't Hoen
-
May 21, 2018
1
2
Page 1 of 2
This work is licensed under Creative Commons.